Capital Research Global Investors
ORCL icon

Capital Research Global Investors’s Oracle ORCL Stock Holding History

Capital Research Global Investors’s Portfolio ORCL Stock Details ORCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.73B Buy
32,139,254
+2,002,128
+7% +$325M 0.73% 30
2025
Q4 		$5.87B Buy
30,137,126
+6,826,299
+29% +$1.63B 1.08% 19
2025
Q3 		$6.56B Buy
23,310,827
+266,588
+1% +$67.9M 1.23% 16
2025
Q2 		$5.04B Buy
23,044,239
+4,033,717
+21% +$651M 1.01% 22
2025
Q1 		$2.66B Buy
19,010,522
+7,055,779
+59% +$1.15B 0.58% 43
2024
Q4 		$1.99B Buy
11,954,743
+4,941
+0% +$878K 0.41% 59
2024
Q3 		$2.04B Buy
11,949,802
+377,815
+3% +$54.7M 0.42% 61
2024
Q2 		$1.63B Buy
+11,571,987
New +$1.44B 0.36% 66
2018
Q2 		– Sell
-5,948,917
Closed -$272M – 454
2018
Q1 		$272M Sell
5,948,917
-13,789,892
-70% -$686M 0.08% 207
2017
Q4 		$933M Sell
19,738,809
-69,005,040
-78% -$3.38B 0.27% 96
2017
Q3 		$4.29B Sell
88,743,849
-52,530,301
-37% -$2.61B 1.3% 16
2017
Q2 		$7.08B Sell
141,274,150
-10,167,433
-7% -$463M 2.22% 5
2017
Q1 		$6.76B Sell
151,441,583
-1,299,624
-0.9% -$54.1M 2.13% 7
2016
Q4 		$5.87B Sell
152,741,207
-8,190,181
-5% -$320M 1.9% 7
2016
Q3 		$6.32B Sell
160,931,388
-2,192,977
-1% -$89.4M 2.09% 6
2016
Q2 		$6.68B Sell
163,124,365
-979,925
-0.6% -$39.1M 2.28% 6
2016
Q1 		$6.71B Sell
164,104,290
-3,662,000
-2% -$136M 2.31% 4
2015
Q4 		$6.13B Buy
167,766,290
+15,386,172
+10% +$588M 2.1% 5
2015
Q3 		$5.5B Buy
152,380,118
+4,245,000
+3% +$163M 1.97% 7
2015
Q2 		$5.97B Buy
148,135,118
+12,064,000
+9% +$523M 1.96% 7
2015
Q1 		$5.87B Buy
136,071,118
+3,057,000
+2% +$132M 2.01% 6
2014
Q4 		$5.98B Sell
133,014,118
-3,329,050
-2% -$135M 2.03% 8
2014
Q3 		$5.22B Sell
136,343,168
-20,336,716
-13% -$823M 1.81% 8
2014
Q2 		$6.35B Sell
156,679,884
-212,300
-0.1% -$8.74M 2.22% 6
2014
Q1 		$6.42B Buy
156,892,184
+3,342,853
+2% +$127M 2.32% 6
2013
Q4 		$5.87B Buy
153,549,331
+5,399,031
+4% +$186M 2.17% 5
2013
Q3 		$4.91B Buy
148,150,300
+22,961,500
+18% +$745M 1.94% 7
2013
Q2 		$3.85B Buy
+125,188,800
New +$4.15B 1.63% 10

Other funds holding ORCL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors's ORCL Position: Q1 2026 in Review

Capital Research Global Investors increased its Oracle (ORCL) stake by 6.6% in Q1 2026, buying an estimated $325M and bringing the position to 32,139,254 shares worth $4.73B. The position accounts for 0.73% of the portfolio, ranked #30.

Capital Research Global Investors first reported a position in ORCL in Q2 2013 and has held it in 28 quarters since. The position peaked at $7.08B in Q2 2017. 3,473 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

  • Capital Research Global Investors held 32,139,254 shares of Oracle worth $4.73B as of Q1 2026.
  • Capital Research Global Investors bought 2,002,128 Oracle shares in Q1 2026, an estimated $325M.
  • Oracle made up 0.73% of Capital Research Global Investors's portfolio in Q1 2026, its #30 holding.
  • Capital Research Global Investors first reported a position in Oracle in Q2 2013 and has held it in 28 quarters since.
  • Capital Research Global Investors's Oracle position peaked at $7.08B in Q2 2017.
  • 3,473 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on Capital Research Global Investors's 13F filing for Q1 2026, filed 13 May 2026.